Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol vs Tramadol + Ketamine for Shivering in C-Section
NCT06134895Phase 4
Key facts
- Status
- Unknown
- Start
- Aug 2023
- Primary completion
- Nov 2023
- Countries
- 1
- Sponsor
- Ziauddin University
- Modality
- Small Molecules
- Drugs
- ketamine
- Conditions
- postanesthetic shivering (PAS)
01
Overview
Phase 4, randomised, double-blind trial of ketamine in postanesthetic shivering (PAS) (2 arms), sponsored by Ziauddin University. Primary endpoints: Incidence of shivering and Severity of Shivering. Status: unknown.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Tramadol with Ketamine
Tramadol 0.25mg/Kg + Ketamine 0.25 mg/Kg
Tramadol
Tramadol 0.5mg/kg
03
Who it enrols
Pregnant females aged 18-40 undergoing lower segment caesarean section with ASA physical status I or II. Excludes patients with hypertension, hypo- or hyperthyroidism, cardiopulmonary disease, pre-eclampsia, eclampsia, or initial body temperature >38.0°C or <36.0°C.
04
Endpoints
Primary
Incidence of shivering
Severity of Shivering
Secondary
Time to shivering
Complications
Beyond the preview
Go deeper on NCT06134895.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06134895.